Description:
Antibody Development For Difficult Targets demands innovative strategies to overcome poor immunogenicity and conformational masking. By combining careful target selection with advanced screening, researchers can identify high-affinity antibodies that translate into robust therapeutic candidates.
Employing orthogonal validation and customised engineering accelerates progress, enabling precise binding and improved developability for complex antigens in challenging disease landscapes.
Social Media
